Selective serotonin reuptake inhibitors. Pharmacology and clinical implications in anaesthesia and critical care medicine

Anaesthesia

Volumn 52, Issue 10, 1997, Pages 982-988

  Kam, P C A ^a   Chang, G W M ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Complications, serotonin syndrome; Interactions (drug); Pharmacology, serotonin reuptake inhibitors, fluoxetine, sertraline, paroxetine

Indexed keywords

ANTIARRHYTHMIC AGENT; CARBAMAZEPINE; CIMETIDINE; DEXTROMETHORPHAN; FLUOXETINE; FLUVOXAMINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PENTAZOCINE; PETHIDINE; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THEOPHYLLINE; TOLBUTAMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; WARFARIN;

AGITATION; ANESTHESIA; ANTICHOLINERGIC EFFECT; CARDIOVASCULAR DISEASE; DEPRESSION; DIARRHEA; HEADACHE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INSOMNIA; INTENSIVE CARE; INTERSTITIAL PNEUMONIA; NAUSEA; PSYCHIATRY; PSYCHOLOGICAL ASPECT; REVIEW; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; TREMOR; VOMITING;

EID: 0030668144     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1997.162-az0176.x     Document Type: Review

References (36)

1. Finley PR. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential distinctions. Annals of Pharmacotherapy 1994; 28: 1359-69.
2. Wong DT, Bymaster FP, Engelman EA. Prozac (Fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its publication. Life Sciences 1995; 50: 411-41.
3. Gram LF. Fluoxetine. New England Journal of Medicine 1994; 331: 1354-61.
4. Benfield P, Heel RC, Lewis SP. Fluoxetine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in depressive illness. Drugs 1986; 32: 481-508.
5. Harris MG, Benfield P. Fluoxetine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness. Drugs and Aging; 1995; 6: 64-84.
6. Murdoch D, McTavish D. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depression and obsessive-compulsive disorder. Drugs 1992; 44: 604-24.
7. Denchant KL, Clissold SP. Paroxetine. A review of its pharmacodynamic and pharmacodynamic properties and therapeutic potential in depressive illness. Drugs 1991; 41: 225-53.
8. Leonard BE. Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance. Drugs 1992; 43: 3-10.
9. Lopez-Ibor JJ. The involvement of serotonin in psychiatric disorders and behaviour. British Journal of Psychiatry 1988; 153 (Suppl. 3): 26-39.
10. Racagni G, Tinelli D, Bianchi E, Brunello N, Perez J. cAMP-dependent binding and endogenous phosphorylation after antidepressant therapy. In: Sandler M, ed. 5-Hydroxytryptamine in Psychiatry. Oxford: Oxford University Press, 1991: 116-23.
11. Kilts CD. Recent pharmacologic advances in antidepressant therapy. American Journal of Medicine 1994; 97 (Suppl. 6A): 3S-12S.
12. Derby LE, Jick H, Dean AD. Antidepressant drugs and suicide. Journal of Clinical Psychopharmacology 1992; 12: 235-40.
13. Drake WM, Gordon GD. Heart block in a patient on propanolol and fluoxetine. Lancet 1994; 343: 126-7.
14. McFaddeen EP, Clarke GJ, Davies GJ. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. New England Journal of Medicine 1991; 324: 688-9.
15. Bass SP, Colebatch HJH. Fluoxetine induced lung damage. Medical Journal of Australia 1992; 156: 364-5.
16. Davies LP. Fluoxetine induced lung damage. Medical Journal of Australia. 1992; 156: 740.
17. Blacksten JV, Birt JA. Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine. Annals of Pharmacotherapy. 1993; 27: 723-4.
18. Adverse Drug Reactions Advisory. Selective serotonin reuptake inhibitors and SIADH. Medical Journal of Australia 1996; 164: 562.
19. Alderman CP, Moritz CK, Ben-Tovim DT. Abnormal platelet aggregation associated with fluoxetine treatment. Annals of Pharmacotherapy 1992; 26: 1517-19.
20. Borys DJ, Setzer SC, Ling LJ, Reisdorf JJ, Day LC, Krenezelok EP. Acute fluoxetine overdose: a report of 234 cases. American Journal of Emergency Medicine 1992; 10: 115-20.
21. Ooi TK. The serotonin syndrome. Anaesthesia 1991; 46: 507-8.
22. Bodner RA, Lynch T, Lewis L, Kahn D. Serotonin syndrome. Neurology 1995; 45: 219-23.
23. Jahr JS, Pisto JD, Gitlin MC, O'Neill PT. The serotonin syndrome in a patient receiving sertraline after an ankle block. Anesthesia and Analgesia 1994; 79: 189-91.
24. Sternbach H. The serotonin syndrome. American Journal of Psychiatry 1991; 148: 705-11.
25. Corkeron MA. Serotonin syndrome - a potentially fatal complication of antidepressant therapy. Medical Journal of Australia 1995; 163: 481-2.
26. Baumann P, Rochat B. Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror. International Clinical Psychopharmacology 1995; 10 (Suppl. 1): 15-21.
27. Nemeroff CB, De Vane L, Pollock BL. Newer antidepressants and the cytochrome P450 system. American Journal of Psychiatry 1996; 153: 311-20.
28. Devane CL. Pharmacokinetics of the newer antidepressants: clinical relevance. American Journal of Medicine 1994; 97 (Suppl. 6A): 13S-23S.
29. Hansen TE, Dieter K, Keepers GA. Interaction of fluoxetine and pentazocine. American Journal of Psychiatry 1990; 417: 949-50.
30. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amytryptyline and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine 1992; 326: 1250-6.
31. Jaffe IA. Serotonin reuptake inhibitors in Raynaud's phenomenon Lancet 1995; 345: 1378.
32. Menkes DB, Taghari E, Mason PA, Spears GFS, Howard RC. Fluoxetine treatment of severe premenstrual syndrome. British Medical Journal 1992; 305: 346-7.
33. Barrickman L, Noyes R, Kuperman S, Schumaker E, Verda M. Treatment of ADHD with fluoxetine: a preliminary trial. Journal of American Academy of Child Adolescent Psychiatry 1991; 30: 762-7.
34. Van Amerigam M, Mancini C, Streiner DL. Fluoxetine efficacy in social phobia. Journal of Clinical Psychiatry 1993; 54: 27-32.
35. Gordon NC, Heller PN, Gear RW, Cervine JD. Interactions between fluoxetine and opiate analgesia for postoperative dental pain. Pain 1994; 58: 85-8.
36. Power BM, Pinder M, Hackett LP, Ilett KF. Fatal serotonin syndrome following a combined overdose of Moclobemide, Clomipramine and Fluoxetine. Anaesthesia and Intensive Care 1995; 23: 499-502.